Otilimab

otilimab · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Otilimab, covering 2022-03-09 to 2022-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease [Phase 2]